Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Synthetic Biologics Discontinues Study of SYN-010 in IBS-C Patients

americanpharmaceuticalreviewOctober 12, 2020

Tag: SYN-010 , IBS-C , CSMC , Synthetic Biologics

PharmaSources Customer Service